New Breast, Lung and Ovarian Cancer Treatment in Phase 1 Clinical Trials in Los Angeles

Share Article

Cancer Center of Southern California participating in clinical trial for advanced breast, non-small cell lung and ovarian cancers, sponsored by Bayer HealthCare.

Cancer Center of Southern California

Cancer Center of Southern California

Clinical trials give us access to the most advanced drug therapies possible and enable us to help more patients.

The Cancer Center of Southern California is participating in the first phase of a two year clinical trial for a new therapeutic drug developed and sponsored by Bayer HealthCare for the treatment of advanced malignancies. Only a select number of national cancer treatment centers are currently involved in the clinical trials at this time. Phase 1 portion is a dose escalation study of the Bayer therapeutic for use in combination with Paclitaxel which is used to treat breast, non-small cell lung, and ovarian cancers.

“Participating in clinical trials is a vital part of our mission,” said Dr. Sant Chawla, director of the Cancer Center of Southern California. “Clinical trials give us access to the most advanced drug therapies possible and enable us to help more patients.”

The purpose of the Bayer HealthCare clinical trial is to identify and evaluate:

  • Treatment's effect on on tumor growth
  • Side effects at different dose levels and schedules
  • Biomarkers explaining why some patients do or do not respond to treatment

Dr. Chawla is a renowned oncologist recognized for his pioneering efforts in groundbreaking clinical drug trials and sarcoma treatment. Dr. Chawla, together with Dr. Kumar Sankhala and Dr. Doris Quon, Cancer Center physician associates, have led investigations for several new therapeutics including TRC105 for angiosarcoma sponsored by the National Cancer Institute and three FDA-approved therapeutics Aldoxorubicin and Pazopanib for soft tissues sarcomas, and Eribulin for metastatic breast cancer.

“Clinical research participation provides innovative drug therapies to our patients,” added Dr. Sankhala, “and we've seen many favorable outcomes as a result.”

Cancer Center of Southern California

Dr. Chawla is Director of the Cancer Center. He is a pioneering physician whose work in sarcoma oncology has brought him praise and international recognition as one of the world’s leading authorities in clinical research and treatment for soft-tissue and bone sarcomas and sarcoma therapy. Dr. Chawla and his colleagues Dr. Sankhala and Dr.Quon treat cancer patients from around the world for whom standard treatments have proven ineffective. The Cancer Center is one of the few places providing dedicated support and treatment for cancer with chemotherapy and other protocols. For additional information visit us on the web at Cancer Center of Southern California.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Risa Goldman
Goldman Marketing Group
+1 818-861-7092
Email >
Cancer Center of Southern California
since: 10/2014
Like >
Visit website